CDC survey findings show 44% of adults reporting GLP-1 use modified their prescribed regimen, highlighting access, cost, counseling, and medication safety concerns.
In a Pharmanews interview, NAPPSA President Dr. Adekunle Tometi outlines priorities for translating health innovations into accessible care in Nigeria, including regulatory reform, manufacturing, research partnerships and responsible digital health.

The flu clinic held as part of the CSR event at NAPPSA's 20th Annual Scientific Conference in Denver vaccinated 65 people.

Congratulations, Dr. Nina Mezu-Nwaba, on receiving the 2026 African Cultural Night Award! Dr. Nina Mezu-Nwaba was honored with...

NAPPSA congratulates Dr. Emmanuel C. Ezirim, RPh, a co-founder and seventh President of the Association, who is profiled in Conglo...

NAPPSA congratulates our President Emerita, Dr. Teresa Isichei Pounds, PharmD, BCNSP, FPCPharm, on receiving the 4th Edition Natio...

NAPPSA congratulates Dr. Emmanuel C. Ezirim, RPh, a former President of the Association, who has been honored with a Lifetime Achi...

NAPPSA Digest is a quarterly publication of the Nigerian Association of Pharmacists and Pharmaceutical Scientists in the Americas

The AJPPS is the official publication of the Nigerian Association of Pharmacists and Pharmaceutical Scientists in the Americas (NAPPSA).

Our 2019-2020 Annual Report is a comprehensive report on NAPPSA’s activities and financial performance through out the preceding year

